Primary Site >> Liver Cancer
Gene >> EPCAM
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. PMID: 18006828 |
Ref: EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. PMID: 19150350 Ref: [Progress and prospects in cancer stem cell research for hepatocellular carcinoma]. PMID: 19728923 |
Ref: Hepatic progenitor cells in liver cancers from Asian children. PMID: 19793197 Ref: Human liver progenitor cell lines are readily established from non-tumorous tissue adjacent to hepatocellular carcinoma. PMID: 19874130 Ref: EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. PMID: 20006402 Ref: Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. PMID: 20461085 Ref: Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. PMID: 20484035 Ref: Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. PMID: 20495535 Ref: Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity. PMID: 20502062 Ref: New strategies in hepatocellular carcinoma: genomic prognostic markers. PMID: 20713493 Ref: Liver-specific Ldb1 deletion results in enhanced liver cancer development. PMID: 20828852 Ref: Analogy between sphere forming ability and stemness of human hepatoma cells. PMID: 20878104 |
Ref: Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. PMID: 20437099 Ref: Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. PMID: 20682318 Ref: Gene expression signature of the gross morphology in hepatocellular carcinoma. PMID: 21233610 Ref: Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. PMID: 21334406 Ref: Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors. PMID: 21344351 Ref: Novel therapeutic strategies for targeting liver cancer stem cells. PMID: 21552419 Ref: The power and the promise of liver cancer stem cell markers. PMID: 21651381 Ref: Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. PMID: 21669008 Ref: Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. PMID: 21711587 Ref: Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PMID: 21731718 Ref: DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. PMID: 21737452 Ref: Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells. PMID: 21826246 Ref: Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology. PMID: 21860552 Ref: [The effect of 5-fluorouracil on enriching cancer stem cells of hepatoma cell line BEL-7402]. PMID: 22152385 Ref: Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells. PMID: 22194816 |
Ref: Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. PMID: 21932402 Ref: Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. PMID: 22201943 Ref: Neighbor of Punc E 11: expression pattern of the new hepatic stem/progenitor cell marker during murine liver development. PMID: 22497843 Ref: Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein. PMID: 22505317 Ref: alpha-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. PMID: 22516245 Ref: Clinical implications of cancer stem cell biology in hepatocellular carcinoma. PMID: 22846863 Ref: CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. PMID: 22904667 Ref: MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PMID: 22962603 Ref: Label-free quantitative proteomics of CD133-positive liver cancer stem cells. PMID: 23170877 Ref: Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PMID: 23185381 Ref: Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation. PMID: 23216644 Ref: Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness. PMID: 23326293 |
Ref: Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines. PMID: 22930170 Ref: The activity of gammadelta T cells against paediatric liver tumour cells and spheroids in cell culture. PMID: 23088518 Ref: Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. PMID: 23174907 Ref: Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. PMID: 23175471 Ref: High expression of cancer stem cell markers in cholangiolocellular carcinoma. PMID: 23192764 Ref: Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis. PMID: 23288052 Ref: Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. PMID: 23388123 Ref: Highly specific and ultrasensitive graphene-enhanced electrochemical detection of low-abundance tumor cells using silica nanoparticles coated with antibody-conjugated quantum dots. PMID: 23402311 Ref: Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. PMID: 23573322 Ref: Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers. PMID: 23685049 Ref: Capture of viable circulating tumor cells in the liver of colorectal cancer patients. PMID: 23695297 Ref: Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model. PMID: 23720769 Ref: Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression. PMID: 23868000 Ref: High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells. PMID: 23879724 Ref: Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma. PMID: 23905013 Ref: Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPss. PMID: 23936298 Ref: [Expression of CD90/EpCAM/CD24 in hepatocellular carcinoma cell lines at various stages of differentiation]. PMID: 24160345 Ref: Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin. PMID: 24312415 |
Ref: Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. PMID: 23958557 Ref: The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. PMID: 24012616 Ref: Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma. PMID: 24028297 Ref: Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature. PMID: 24030743 Ref: EpCAM-targeted therapy for human hepatocellular carcinoma. PMID: 24370904 Ref: Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer. PMID: 24448820 Ref: Diversity of hepatocellular carcinoma clones bearing hematopoietic malignancies-related chromosomal translocation. PMID: 24453043 Ref: Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma. PMID: 24506513 Ref: The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma. PMID: 24816638 Ref: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 24892648 Ref: Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform. PMID: 25009297 Ref: Circulating tumor cells in the central and peripheral venous compartment - assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. PMID: 25071374 Ref: Smart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinoma. PMID: 25089503 Ref: Construction of carbon nanotube based nanoarchitectures for selective impedimetric detection of cancer cells in whole blood. PMID: 25110907 Ref: IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma. PMID: 25123037 Ref: MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism. PMID: 25189530 Ref: Proliferative ductular reactions correlate with hepatic progenitor cell and predict recurrence in HCC patients after curative resection. PMID: 25197550 Ref: C-KIT-positive undifferentiated tumor of the liver: A case report. PMID: 25202388 Ref: Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics. PMID: 25376296 Ref: Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients. PMID: 25593983 Ref: Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma. PMID: 26034695 |
Ref: Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3beta/beta-catenin pathway. PMID: 23857500 Ref: A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. PMID: 25053293 Ref: Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice. PMID: 25087473 Ref: TGF-beta signaling alters the pattern of liver tumorigenesis induced by Pten inactivation. PMID: 25132272 Ref: Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma. PMID: 25271001 Ref: betaII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. PMID: 25307947 Ref: Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma. PMID: 25404478 Ref: Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas. PMID: 25519836 Ref: Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma. PMID: 25597408 Ref: Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver. PMID: 25785486 Ref: Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma. PMID: 25791790 Ref: Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. PMID: 25828473 Ref: PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis. PMID: 25855382 Ref: Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib. PMID: 25885470 Ref: Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of beta-Catenin in Mice. PMID: 26033745 Ref: Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma. PMID: 26095183 Ref: Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma. PMID: 26110787 Ref: Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis. PMID: 26124671 Ref: ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma. PMID: 26160842 Ref: Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA). PMID: 26252310 Ref: Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients. PMID: 26287250 Ref: beta-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study. PMID: 26311355 Ref: A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. PMID: 26376676 Ref: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells. PMID: 26420065 Ref: LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. PMID: 26540343 Ref: Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association. PMID: 26609030 |
Ref: Clinicopathological indices to predict hepatocellular carcinoma molecular classification. PMID: 26058462 Ref: Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. PMID: 26586401 Ref: MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK. PMID: 26711788 Ref: Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. PMID: 26812074 Ref: Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma. PMID: 26880118 Ref: [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases]. PMID: 26956962 Ref: Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells. PMID: 27050147 Ref: Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcgamma receptors. PMID: 27058902 Ref: Intratumor heterogeneity, variability and plasticity: questioning the current concepts in classification and treatment of hepatocellular carcinoma. PMID: 27115013 Ref: Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells. PMID: 27123080 Ref: Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma? PMID: 27132171 Ref: AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis. PMID: 27160647 Ref: Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation. PMID: 27161394 Ref: De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas. PMID: 27191501 Ref: Biofunctionalized magnetic nanospheres-based cell sorting strategy for efficient isolation, detection and subtype analyses of heterogeneous circulating hepatocellular carcinoma cells. PMID: 27240010 Ref: Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. PMID: 27312064 Ref: Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models. PMID: 27329727 Ref: Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. PMID: 27439521 Ref: Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. PMID: 27447573 Ref: Construction of Epidermal Growth Factor Receptor Peptide Magnetic Nanovesicles with Lipid Bilayers for Enhanced Capture of Liver Cancer Circulating Tumor Cells. PMID: 27558867 Ref: Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation. PMID: 27683116 Ref: WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3beta/beta-catenin signaling pathway. PMID: 27783993 Ref: miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma. PMID: 27835990 Ref: Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry. PMID: 28009002 Ref: Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis. PMID: 28337100 Ref: High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells. PMID: 28955945 |
Ref: Prognostic relevance of miR-137 in patients with hepatocellular carcinoma. PMID: 27473646 Ref: BRAF V600E mutation in biliary proliferations associated with alpha1 -antitrypsin deficiency. PMID: 27627051 Ref: Long noncoding RNA TCF7 promotes invasiveness and self-renewal of human non-small cell lung cancer cells. PMID: 27766570 Ref: A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways. PMID: 27773936 Ref: Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/beta-catenin pathway. PMID: 27911878 Ref: HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway. PMID: 27925189 Ref: Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis. PMID: 28114366 Ref: Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties. PMID: 28152020 Ref: Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma. PMID: 28267620 Ref: Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma. PMID: 28326574 Ref: Anterior Approach to Improve the Prognosis in HCC Patients Via Decreasing Dissemination of EpCAM(+) Circulating Tumor Cells. PMID: 28378318 Ref: The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma. PMID: 28383782 Ref: Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter. PMID: 28414325 Ref: Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-beta/Smad-regulated liver cancer stem cell-like cells. PMID: 28415588 Ref: Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro. PMID: 28419472 Ref: Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging. PMID: 28550313 Ref: Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B. PMID: 28566884 Ref: Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma. PMID: 28572700 Ref: The C-terminus domain of the hepatitis B virus x protein stimulates the proliferation of mouse foetal hepatic progenitor cells, although it is not required for the formation of spheroids. PMID: 28627604 Ref: HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition. PMID: 28646927 Ref: A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma. PMID: 28668827 Ref: Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells. PMID: 28716525 Ref: Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma - an immunohistochemical study. PMID: 28764740 Ref: Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90. PMID: 28900199 Ref: Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. PMID: 28930164 Ref: Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma. PMID: 28951464 Ref: Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma. PMID: 29075151 Ref: Corrigendum to "Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma". PMID: 29085181 Ref: CYP3A4 Gene Is a Novel Biomarker for Predicting a Poor Prognosis in Hepatocellular Carcinoma. PMID: 29109094 Ref: Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. PMID: 29163804 |
Ref: Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. PMID: 28982688 Ref: Quantified postsurgical small cell size CTCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse. PMID: 29031565 Ref: High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma. PMID: 29138811 Ref: NF-kappaB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite. PMID: 29240254 Ref: MicroRNA-191, regulated by HIF-2alpha, is involved in EMT and acquisition of a stem cell-like phenotype in arsenite-transformed human liver epithelial cells. PMID: 29277653 Ref: EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells. PMID: 29298343 Ref: Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance. PMID: 29414601 Ref: Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. PMID: 29497050 Ref: Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. PMID: 29545603 Ref: Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice. PMID: 29567647 Ref: Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo. PMID: 29662633 Ref: Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. PMID: 29686061 Ref: Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. PMID: 29915159 Ref: Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines. PMID: 30069818 Ref: Enrichment of cancer stem cells via beta-catenin contributing to the tumorigenesis of hepatocellular carcinoma. PMID: 30075764 Ref: Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma. PMID: 30112355 Ref: Pten Haplodeficiency Accelerates Liver Tumor Growth in miR-122a-Null Mice via Expansion of Periportal Hepatocyte-Like Cells. PMID: 30165041 Ref: Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model. PMID: 30177788 Ref: miR-365 Regulates Liver Cancer Stem Cells via RAC1 pathway. PMID: 30182377 Ref: Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma. PMID: 30186744 Ref: 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12. PMID: 30301668 Ref: Microporous cellulosic scaffold as a spheroid culture system modulates chemotherapeutic responses and stemness in hepatocellular carcinoma. PMID: 30302811 Ref: Long non-coding RNA THOR promotes liver cancer stem cells expansion via beta-catenin pathway. PMID: 30359743 |